Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) CAO Ryan M. Bartolucci sold 339 shares of the firm’s stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $40.23, for a total value of $13,637.97. Following the completion of the sale, the chief accounting officer now directly owns 71,007 shares in the company, valued at approximately $2,856,611.61. The trade was a 0.48 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this link.
Tempus AI Price Performance
NASDAQ TEM opened at $33.03 on Friday. The stock’s fifty day moving average price is $51.96. Tempus AI, Inc. has a 52 week low of $22.89 and a 52 week high of $79.49. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.
Analyst Upgrades and Downgrades
Several brokerages recently commented on TEM. Piper Sandler reissued a “neutral” rating and issued a $70.00 price target (up previously from $40.00) on shares of Tempus AI in a report on Tuesday, November 12th. Guggenheim initiated coverage on Tempus AI in a research note on Monday, December 9th. They issued a “buy” rating and a $74.00 price objective for the company. Bank of America upped their target price on shares of Tempus AI from $52.00 to $54.00 and gave the stock a “neutral” rating in a report on Friday, December 13th. Stifel Nicolaus cut shares of Tempus AI from a “buy” rating to a “hold” rating and increased their target price for the company from $45.00 to $65.00 in a research report on Monday, November 11th. Finally, Loop Capital raised their target price on shares of Tempus AI from $48.00 to $57.00 and gave the stock a “buy” rating in a research note on Tuesday, October 15th. Three equities research analysts have rated the stock with a hold rating and nine have issued a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $56.00.
Hedge Funds Weigh In On Tempus AI
A number of institutional investors have recently added to or reduced their stakes in TEM. Franklin Resources Inc. raised its position in shares of Tempus AI by 1.0% in the 3rd quarter. Franklin Resources Inc. now owns 811,311 shares of the company’s stock valued at $45,920,000 after purchasing an additional 8,387 shares in the last quarter. Tidal Investments LLC bought a new stake in shares of Tempus AI in the third quarter worth $7,633,000. Teachers Retirement System of The State of Kentucky raised its holdings in Tempus AI by 6.3% in the third quarter. Teachers Retirement System of The State of Kentucky now owns 126,500 shares of the company’s stock valued at $7,160,000 after acquiring an additional 7,500 shares in the last quarter. Geode Capital Management LLC boosted its stake in Tempus AI by 0.4% during the 3rd quarter. Geode Capital Management LLC now owns 133,171 shares of the company’s stock valued at $7,537,000 after acquiring an additional 539 shares during the last quarter. Finally, XTX Topco Ltd acquired a new position in Tempus AI during the 3rd quarter worth $502,000. Institutional investors and hedge funds own 24.22% of the company’s stock.
Tempus AI Company Profile
Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.
Featured Stories
- Five stocks we like better than Tempus AI
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Beyond Reality: Investing in AR/VR Tech for Future Gains
- Top Biotech Stocks: Exploring Innovation Opportunities
- Palantir’s Momentum Persists Despite Market Worries
- What Are Treasury Bonds?
- Ad Sales to Top $1 Trillion: 3 Stocks to Take Advantage
Receive News & Ratings for Tempus AI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tempus AI and related companies with MarketBeat.com's FREE daily email newsletter.